AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiyes M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Pharvax Biosciences

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimiyes M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication, indicated for adult-onset type 2 diabetes, effectively manages blood glucose levels. Diabex Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, manifested by sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is vital. Alcohol consumption should be limited due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Primary Ingredients of Glimiyes M 1mg/500mg Tablet SR

The provided text is "undefined," therefore no rewriting is possible.

Uses of Glimiyes M 1mg/500mg Tablet SR

Managing Type 2 diabetes

Major Benefits of Glimiyes M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimiyes M 1mg/500mg Sustained-Release Tablets should be administered with a meal.

Common Side effects of Glimiyes M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiyes M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiyes M 1mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this extended-release tablet with food.

How Glimiyes M 1mg/500mg Tablet SR works:

Glimiyes M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glimiyes M 1mg/500mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimiyes M 1mg/500mg SR tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Glimiyes M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Glimiyes M 1mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not use Glimiyes M 1mg/500mg SR tablets. Medical supervision, including regular kidney function assessments, is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimiyes M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glimiyes M 1mg/500mg Tablet SR :

Should you forget to take your Glimiyes M 1mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimiyes M 1mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Treatment

FAQs on Glimiyes M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimiyes M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and a slow heart rate. Seek immediate medical attention and discontinue Glimiyes M 1mg/500mg Tablet SR if these symptoms occur.
Glimiyes M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimiyes M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimiperide M 1mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimiperide/metformin (Glimiyes M 1mg/500mg SR) can lower your blood sugar (causing hypoglycemia). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases if you skip meals, drink alcohol, overexercise, or take other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiyes M 1mg/500mg SR tablets with alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimiyes M 1mg/500mg Tabl...
37
MRP 45
17% off